跳至主要内容
临床试验/TCTR20190107001
TCTR20190107001招募中未知

Bioequivalence Study of Two Formulations of Tramadol Capsules in Healthy Myanmar Volunteers

Implementation research grant (ID-197, 2018) from the Ministry of Health and Sports, Myanmar0 个研究点目标入组 16 人开始时间: 2019年1月7日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
16

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 55 Years(—)
性别
All

入选标准

  • 1.Age: 18-55 years
  • 2.Sex: either sex
  • 3.BMI: 18-30 kg/m2
  • 4.Non-smoker
  • 5.Non-drinker
  • 6.Persons whose Chest X rays, Blood for complete picture, liver enzymes (ALT, AST), Electrocardiograph (ECG), Random Blood Sugar (RBS) and renal function test (urea, creatinine) are within normal limits at the beginning of the study

排除标准

  • 1.Subjects with history of allergic reactions to Tramadol
  • 2.History of epilepsy

研究者

发起方
Implementation research grant (ID-197, 2018) from the Ministry of Health and Sports, Myanmar

相似试验

尚未招募
1 期
A Bioequivalence Study of Two Formulations of 25 mg Pregabalin Capsules in Healthy Thai Volunteers under Fasting Conditionshealthy volunteerPregabalin Bioequivalence
TCTR20230208004Faculty of Medicine Siriraj Hospital28
尚未招募
不适用
Bioequivalance study of Tramadole 100 mg Tablets
IRCT20200513047423N7Shahrdaru Pharmaceutical Co.24
尚未招募
1 期
A Bioequivalence Study of Dabigatran Etexilate Capsules under Fasting ConditionsPrevention of venous thromboembolism (VTE) in adult patients who have undergone elective hip or knee replacement surgery, treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), prevention of recurrent DVT and PE, and prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation (AF)Bioequivalence, Dabigatran, Dabigatran etexilate, generic dabigatran, generic dabigatran etexilate, pharmacokinetics
TCTR20210819001MSN Laboratories Private Limited42
尚未招募
1 期
A Bioequivalence Study of Two Formulations of 25-mg Empagliflozin Tablets in Healthy Thai Volunteers under Fasting ConditionsHealthy Thai Volunteers
TCTR20221003003Siriraj Institute of Clinical Research (SICRES)28
Unknown
1 期
A Bioequivalence Study of Two Formulations of 20-mg Rabeprazole Sodium Gastro-resistant Tablets in Healthy Thai Subjects under Fed ConditionsGERD, heartburn symptoms, duodenal ulcers, hypersecretory conditions, Zollinger-Ellison SyndromeGERD, Ulcer, Zollinger-Ellison Syndrome
TCTR20221104006KOREA UNITED PHARM. INC.40